| Date Filed | Type | Description |
| 09/02/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/30/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/30/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/30/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/30/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/30/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/04/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/04/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/04/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/03/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/03/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/15/2022 |
SC 13D/A
| Ospraie Ag Science LLC reports a 0% stake in Marrone Bio Innovations, Inc. |
| 07/12/2022 |
8-K
| Quarterly results |
| 07/12/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/11/2022 |
8-K
| Quarterly results |
| 06/30/2022 |
8-K
| Quarterly results |
| 06/09/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 05/19/2022 |
8-K
| Quarterly results |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/11/2022 |
8-K
| Quarterly results |
| 05/09/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 04/29/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/29/2022 |
SC 13G/A
| VAN HERK INVESTMENTS B.V. reports a 4.7% stake in Marrone Bio Innovations, Inc. |
| 03/28/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/23/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
|